Dear colleagues,

New approaches to utilizing the immune system in the fight against disease hold great promise. 425 related clinical trials are currently under way for cancer therapy alone, 60 of them in phase III. Obviously, the classical field of active and passive vaccination, i.e. the prevention and treatment of infectious diseases will also benefit from innovations in immune therapy.

The conference will bring together industrial and academic researchers to discuss progress as well as open questions and issues in current strategies. We invite you to take part in this outstanding scientific event.

Würzburg is steeped in history, with more than 600 years of university history alone. The city harbours countless treasures of art and architecture and has been the center of a famous wine area since the 7th Century. The arts and the art of living are here to be enjoyed!

We look forward to welcoming you in Würzburg.

Prof. Dr. Ulf R. Rapp                Prof. Dr. Jörg Hacker
Chairman of                            Speaker of
BioMedTec Franken e.V.          forimmun
 

Supported by